Is Cardinal Health Building a New Tech

Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?

Cardinal Health’s CAH fiscal 2026 results suggest that technology is becoming an increasingly important layer across its healthcare infrastructure, complementing its traditional distribution capabilities. The company has invested heavily in automation, technology and advanced analytics across its distribution network, with management citing meaningful gains in efficiency and service performance. These investments are translating into measurable operational benefits: Cardinal’s total fill rate reached nearly 99%, while the company recorded its best quarter for on-time departures.

The transformation is particularly visible in Sonexus, Cardinal Health’s specialty access and patient-support business. Rather than operating Sonexus as a standalone service, Cardinal Health has integrated it directly into the Nuclear business’ web-ordering platform. The result is an end-to-end digital workflow for high-cost radiopharmaceuticals, combining insurance-benefit verification, patient enrollment and order placement within a single system. This integration potentially reduces friction across a highly complex healthcare transaction while improving the experience for providers and patients.

Technology is also reshaping Cardinal Health’s logistics offering. OptiFreight is expanding its technology-enabled products, including Shipment Navigator and Tracking Beacon, which are designed to provide customers with greater visibility and insights into outbound pharmacy shipments. Management said adoption has been strong, as these solutions are built to generate cost savings and efficiency for healthcare providers.

The broader strategy is therefore moving beyond simply distributing pharmaceuticals and medical products. Cardinal Health is increasingly connecting distribution, specialty services, patient support and logistics through digital workflows. Its Consumer Health Logistics Center, meanwhile, has used technology and automation to improve service levels and customer access.

The financial opportunity lies in making these investments scalable. Cardinal expects $700 million of fiscal 2027 capital expenditures, including infrastructure and technology investments supporting future growth. If technology continues improving throughput, accuracy, customer experience and supply-chain visibility, Cardinal Health could increasingly operate as a tech-enabled healthcare platform rather than a conventional distributor.

CONMED CNMD is building its technology proposition around AirSeal, using differentiated surgical technology and clinical evidence to improve procedure efficiency and outcomes. AirSeal’s low-pressure insufflation platform is designed to improve visualization, reduce procedure times, postoperative pain and length of stay, making it increasingly relevant as robotic surgery expands across specialties and ASCs. CONMED is also generating ASC-specific economic data and expanding clinical relationships in laparoscopic applications such as colorectal and gynecology. With AirSeal currently used in only 6-7% of more than 3 million U.S. laparoscopic procedures, the company has substantial room to expand utilization. Management expects long-term AirSeal growth of high-single-digit to low-double-digit rates.

Align Technology ALGN is developing a broader digital healthcare platform that connects imaging, diagnostics, treatment planning and treatment delivery. Its Align Digital Platform integrates iTero scanners, Invisalign, exocad and X-ray Insight software, creating a connected workflow spanning orthodontic and restorative dentistry. New platform capabilities are designed to improve patient engagement, treatment planning and workflow efficiency, while software, visualization, digital planning and 3D printing help doctors increase practice productivity. The strategy is also expanding the installed scanner base through lower-cost configurations, leasing and rental models, which can increase digital adoption and create a larger funnel for higher-margin, recurring treatment revenue. With active scanner units up 11% year over year and scans rising 16%, growing platform utilization could reinforce Align’s long-term competitive moat.

CAH’s Price Performance, Valuation and Estimates

Shares of CAH have gained 17.5% so far this year compared with the industry’s 7.3% growth.

From a valuation standpoint, Cardinal Health trades at a forward price-to-earnings of 19.2X, above the industry average. However, it is trading lower than its five-year high of 22.19X. CAH carries a Value Score of A.

The Zacks Consensus Estimate for Cardinal Health’s fiscal 2027 earnings implies an 11.5% rise from the year-ago reported number.

The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cardinal Health, Inc. (CAH): Free Stock Analysis Report

CONMED Corporation (CNMD): Free Stock Analysis Report

Align Technology, Inc. (ALGN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).